---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-012785"
form_type: "8-K"
ticker: "TELO"
cik: "0001971532"
company_name: "Telomir Pharmaceuticals, Inc."
filed_at: "2025-05-29T23:59:59+00:00"
generated_at: "2026-05-20T06:48:02.201561+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Telomir Pharmaceuticals reports Telomir-1 restores vision in AMD animal model

## Summary
- Telomir-1 improved central vision response and motion detection in AMD zebrafish model.
- Retinal layer regeneration observed: INL, GCL, IPL, OPL thickness increased.
- Reactive oxygen species reduced ~50% vs. untreated; 15% mortality in controls vs. 0% in treated.
- Results support continued advancement toward IND submission.

## SEC filing metadata
- accession: 0001641172-25-012785
- form_type: 8-K
- ticker: TELO
- cik: 0001971532
- company_name: Telomir Pharmaceuticals, Inc.
- filed_at: 2025-05-29T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971532/000164117225012785/0001641172-25-012785-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971532/000164117225012785/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-012785
- JSON: https://secwatch.observer/filing/0001641172-25-012785.json
- Plain text: https://secwatch.observer/filing/0001641172-25-012785.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.